Top Reason Imricor Medical Systems (ASX:IMR) Is Back in Focus After Key FDA Win
Highlights Imricor Medical Systems has secured expanded United States regulatory clearance for its MRI-guided cardiac ablation technology. The approval allows the company's NorthStar system and Vision-MR diagnostic catheter to be marketed for use in both children and adults. The latest milestone broadens the company's commercial opportunity as it continues expanding its presence in MRI-guided cardiac procedures. Australia's healthcare sector continues to a...

